We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 18, 2020

PFS Benefit With Combined Endocrine Approaches in Elderly Patients With HR+/HER2– Advanced Breast Cancer

BMC Cancer

 

Additional Info

BMC Cancer
Combined Endocrine Approaches vs Endocrine Therapy Alone as First Line Treatment in Elderly Patients With Hormone Receptor-Positive, HER2 Negative, Advanced Breast Cancer: To Prescribe for the Patient or the Physician? A Meta-Analysis of Phase II and III Randomized Clinical Trials
BMC Cancer 2020 May 13;[EPub Ahead of Print], C Omarini, F Piacentini, I Sperduti, M Barbolini, C Isca, A Toss, L Cortesi, E Barbieri, M Dominici, L Moscetti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading